Physician profile
Brittney N Anders
NPI 1538556808
$5,794.06
in general payments reported to CMS, 2019-2025
22 companies · $3,567 in 2025
The $3,567 reported for 2025 was more than what 97% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.03 · 2020: $63.22 · 2021: $23.13 · 2022: $75.10 · 2023: $165 · 2024: $1,877 · 2025: $3,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,400 · Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,400.00 |
| Food and Beverage | $1,208.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $4,400.00 | 2024-2025 | Bovine Collagen |
| Organon LLC | $318.74 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $241.18 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $126.50 | 2024-2025 | Slynd |
| Pfizer INC. | $114.34 | 2023-2025 | |
| Shield Therapeutics INC | $96.62 | 2025 | |
| Abbvie INC. | $93.11 | 2020-2025 | Liletta, Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $61.88 | 2021-2025 | |
| Astellas Pharma US INC | $55.68 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $36.12 | 2022 | |
| Sage Therapeutics, LLC | $34.89 | 2025 | Zurzuvae |
| Novo Nordisk INC | $34.43 | 2024-2025 | Wegovy |
| Millicent US INC | $31.84 | 2025 | Intrarosa, Femring, Femlyv |
| Meditrina | $30.35 | 2024-2025 | |
| Daiichi Sankyo INC. | $17.41 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.95 | 2022 | |
| Supernus Pharmaceuticals, INC. | $16.91 | 2025 | Qelbree |
| Lupin INC. | $16.37 | 2020 | |
| Coopersurgical, INC. | $14.12 | 2025 | |
| Allergan, INC. | $12.59 | 2020 | |
| Merck Sharp & Dohme LLC | $12.15 | 2019 | |
| Therapeuticsmd, INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.